Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
Β 

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

Β 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

Β 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

Β 

18,837

0.03

18,837

Β 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

Β 

15,776

0.03

15,776

Β 

Β 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

Β 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

Β 

APPENDIXΒ 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of Β£14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

Β 

Β 

c)

Β 

Β 

Β 

Price(s) and volume(s)

Β 

Β 

1. Exercise of PSS awards

Β 

2. Exercise of options

Β 

3. Call of DBP awards

Β 

4. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

19,749

Β 

Β£14.46

12,707

Β£0.00

11,302

Β£29.10

43,758

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards, exercise of options with an exercise price of Β£14.46 and call of DBP awards: 43,758

Β 

Sale of shares: 43,758

Β 

Exercise of PSS awards (Β£nil), exercise of options with an exercise price of Β£14.46 (Β£14.46) and call of DBP awards (Β£nil): weighted average price Β£4.20

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards, options with an exercise price of Β£14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stephen Anthony King

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

Β 

Price(s) and volume(s)

Β 

Β 

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

11,194

Β 

Β£0.00

13,365

Β£29.10

24,559

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 24,559

Β 

Sale of shares: 24,559

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

15,776

Β 

Β£0.00

18,837

Β£29.10

34,613

Β 

Β 

Β 

Β 

Β 

d)

Β 

Β 

Β 

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 34,613

Β 

Sale of shares: 34,613

Β 

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSSUFDAFWSEEM
Date   Source Headline
27th Aug 20215:10 pmRNSTransaction in Own Shares
20th Aug 20214:56 pmRNSTransaction in Own Shares
20th Aug 202110:41 amRNSHolding(s) in Company
13th Aug 20215:13 pmRNSTransaction in Own Shares
9th Aug 202112:12 pmRNSHolding(s) in Company
6th Aug 20215:10 pmRNSTransaction in Own Shares
5th Aug 20219:19 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20215:23 pmRNSTransaction in Own Shares
21st Jul 20215:18 pmRNSGovernance Committee Membership
21st Jul 20215:14 pmRNSResult of AGM
16th Jul 20215:08 pmRNSTransaction in Own Shares
16th Jul 20214:29 pmRNSChange of Auditor
7th Jul 202111:50 amRNSNet Asset Value(s) and Portfolio Update
30th Jun 20215:51 pmRNSTotal Voting Rights
30th Jun 20215:50 pmRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20215:09 pmRNSAnnual Financial Report
10th Jun 20219:01 amRNSHolding(s) in Company
7th Jun 20214:46 pmRNSDirector/PDMR Shareholding
7th Jun 20214:37 pmRNSDirector/PDMR Shareholding
4th Jun 202111:58 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSCaledonia Private Capital sells DSE
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.